• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
%{topic} RSS Feed RSS

FDA Will Heavily Investigate AstraZeneca Vaccine Safety Issue, Hahn Says

September 21, 2020
Health regulators abroad have begun giving the OK for AstraZeneca to resume its phase 3 COVID-19 vaccine trial following a single unexplained patient illness, but the FDA has still not cleared the trial to start back up, with FDA Commissioner Stephen Hahn saying the agency will engage in “very significant work” with the company to unravel the safety issue. Read More

COVID-19 Update

September 21, 2020
COVID-19 Drug Research Roundup Read More

Drugmakers Pledge Science over Speed in Vaccine Trials

September 14, 2020
The CEOs of nine pharmaceutical companies racing to develop COVID-19 vaccines made an unprecedented pledge last week to “uphold the integrity of the scientific process” in the trials they are conducting for vaccine approval. Read More

AstraZeneca Halts Phase 3 Vaccine Trial over Possible Serious Adverse Reaction

September 14, 2020
AstraZeneca has paused a late-stage trial of its promising COVID-19 vaccine candidate while it evaluates a single UK patient who may have experienced a serious adverse reaction. Read More

COVID-19 Update

September 14, 2020
COVID-19 Drug Research Roundup Read More
BurdeninGray-360x240.png

Sites Overwhelmed by Cost and Trial Complexity, Need Sponsor Help to Bear the Burden

September 14, 2020
Leslie Ramsey
Dwindling clinical trial financial resources caused by COVID-19 and declining investigator participation are clashing with sponsors’ demand for more — and more complex — trials, creating a “perfect storm” of pressure that threatens to overwhelm the research industry if sites and sponsors don’t work together to adjust to the realities of life in a pandemic. Read More

Biotech CEOs Publish Open Letter on FDA Independence and COVID-19 Trial Transparency

September 7, 2020
In an open letter by the Biotechnology Innovation Organization (BIO) published last week, a group of biotech CEOs argued that political considerations should be put aside by both major political parties and the conclusions about the safety and efficacy of COVID-19 therapies should only be based on rigorous data collection and assessment by appropriate bodies. Read More

FDA Updates Guidance on COVID-19 Convalescent Plasma Use

September 7, 2020
The FDA has updated its guidance on the use of convalescent plasma to treat COVID-19 or in clinical trials of the treatment to take account of the Trump administration’s Aug. 23 Emergency Use Authorization (EUA). Read More

COVID-19 Update

September 7, 2020
COVID-19 Drug Research Roundup Read More

Investigators Concerned Fewer Patients With COVID-19 Will Enroll in Plasma Studies

August 31, 2020
The FDA’s decision to grant Emergency Use Authorization (EUA) for convalescent plasma in patients with COVID-19 has led many investigators to voice concerns that not enough patients with the infection will enroll in randomized controlled trials of the therapy going forward. Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 17 18 Next

Upcoming Events

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

  • VaccinewithNeedle-360x240.png

    2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

  • Dominate-360x240.png

    COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing